INTRODUCTION
============

Ribonuclease P (RNase P), an essential ribonucleoprotein enzyme, catalyzes the 5′-end maturation of tRNAs in all Kingdoms of life ([@B1],[@B2]). The bacterial RNase P holoenzyme consists of an RNA subunit (P RNA) of approximately 400 nt and a small basic protein (P protein) of approximately. 13 kDa. *In vitro*, RNA subunits of bacterial RNase P enzymes are catalytically active in the absence of the protein subunit ([@B3]), but the protein is essential *in vivo* ([@B4],[@B5]). Two major architectural subtypes of bacterial P RNA are known, type A (for [a]{.ul}ncestral, prototype *Escherichia coli*) and type B (represented by *[B]{.ul}acillus subtilis*) ([@B6]), each containing several secondary structural elements not present in the other. A major difference between type A and B structures is the L15 loop of the catalytic domain, which is an internal one in type A but apical in type B RNAs ([Figure 1](#F1){ref-type="fig"}A--C). For *E. coli* P RNA, the model system of type A structures, it has been shown that two conserved G residues (G293 and G292) in L15 form Watson--Crick base pairs with the two cytosines of tRNA 3′-[CC]{.ul}A (C~74~ and C~75~) termini ([@B8]). Several *in vitro* studies focussing on the *E. coli* RNA-alone reaction have indicated that the CCA contact increases substrate affinity ([@B9; @B10; @B11]) and supports selection of the correct cleavage site ([@B8],[@B12]) as well as catalysis ([@B10],[@B11],[@B13]). Recently, disruption of this interaction was demonstrated to be lethal for *E. coli* cells ([@B14]). Analysis of processing of 4.5S RNA, a non-tRNA substrate of RNase P in *E. coli*, revealed that restoration of base pairing by an isosteric C293-G~74~ base pair, but not a C292-G~75~ pair, fully rescued catalytic performance *in vivo*. *In vitro* activity assays of *E. coli* wild type (wt) and C292/C293 mutant RNase P holoenzymes at magnesium concentrations as low as 2 mM Mg^2+^ suggested a defect in the recruitment of catalytically active Mg^2+^ ions as the major cause for the lethal phenotype of the mutant P RNAs ([@B14]). Figure 1.Secondary structure illustrations of (**A**) *Bacillus subtilis* (type B), (**B**) *Staphylococcus aureus* (type B) and (**C**) *Escherichia coli* (type A) RNase P RNA according to ([@B7]). The two G residues in L15, known (*E. coli*) or suspected (*B. subtilis, S. aureus*) to be involved in the interaction with tRNA 3′-CCA, are highlighted by gray ovals. (**D**) Proposed interaction of a canonical bacterial ptRNA (*Thermus thermophilus* ptRNA^Gly^) with the L15 loop of *B. subtilis* RNase P RNA. Highlighted nucleotides mark the sites of mutation investigated in this study. The arrow indicates the canonical RNase P cleavage site (between nucleotide --1 and +1).

Type B RNase P RNAs, represented by those from *B. subtilis* and *Staphylococcus aureus*, also encode a conserved GG dinucleotide in their L15 loop ([Figure 1](#F1){ref-type="fig"}A and B, G258/G259 in *B. subtilis* and G238/G239 in *S. aureus* P RNA). Photo-crosslinking of *E. coli* and *B. subtilis* P RNAs to tRNAs with photoreactive groups at the 3′-end has indicated that in enzyme--substrate complexes of both P RNA types the tRNA 3′-CCA terminus is positioned close to the L15 loop region ([@B15]). G258 and G259 of *B. subtilis* P RNA were further shown to be protected from kethoxal modification upon complexation with mature tRNA or precursor tRNA (ptRNA), and this protection was reduced with ptRNA lacking 3′-CCA ([@B16]). Potential base pairing to 3′-CCA was addressed by testing cleavage-site selection in L15 mutants of two type A RNAs (from *E. coli* and *Mycobacterium tuberculosis*) and of the type B RNA from *Mycoplasma hyopneumoniae*. With *M. hyopneumoniae* P RNA, some of the observed mutational effects were consistent with base pairing to 3′-CCA, but the results were not as conclusive as for the type A RNAs ([@B12]).

The physiological role of a CCA contact has remained unclear in view of the observation that *B. subtilis* P RNA, in contrast to its *E. coli* counterpart, is rather insensitive to 3′-CCA mutations in terms of cleavage-site selection ([@B17]). Furthermore, the P protein of *B. subtilis* RNase P increases the affinity for the ptRNA more than 10^4^-fold ([@B18],[@B19]), raising the question whether a contribution of the CCA interaction to substrate affinity of type B enzymes would be significant. Also, the Michaelis constant *K*~m~ in multiple turnover reactions of the *B. subtilis* RNase P holoenzyme remained unaffected by the absence of CCA ([@B15]).

Furthermore, one-third of tRNAs (27 out of 86) in *B. subtilis* do not have the CCA motif encoded by their genes. RNase Z removes the 3′-trailers of such CCA-less tRNA primary transcripts by endonucleolytic cleavage 3′ of the discriminator nucleotide as a prerequisite for CCA addition by tRNA nucleotidyl-transferase (CCase); since RNase Z is blocked by the presence of 3′-CCA, it acts specifically on tRNA transcripts lacking the 3′-CCA motif ([@B20]). However, *B. subtilis* RNase Z activity inversely correlates with the length of tRNA 5′ extensions, which led to the proposal that processing by RNase P precedes that of RNase Z in the case of tRNA transcripts with larger 5′ extensions (\>30 nt) ([@B20]). This would suggest that *in vivo B. subtilis* RNase P might be able to process certain substrates in the absence of a 3′-CCA moiety.

Here we have analyzed the role of the CCA interaction by mutational analysis *in vitro* and *in vivo* in type B bacteria. We demonstrate that *B. subtilis rnpB*C258 and *rnpB*C259 mutant alleles carrying a G to C258 or G to C259 mutation in L15 are lethal in the *B. subtilis rnpB* mutant strain SSB318. We also included a second type B RNA from *S. aureus* in our complementation study. Corresponding *S. aureus rnpB*C238 and *rnpB*C239 mutant alleles also decreased cell viability of *B. subtili*s SSB318 cells, although not being lethal. Even though the growth defects could be (partially) rescued by parallel overexpression of the *B. subtilis* P protein, we found no evidence for defects of the mutant P RNAs in P protein or substrate binding. Rather, processing assays with *in vitro* assembled holoenzymes revealed a defect of the C258/C259 mutant enzymes at free Mg^2+^ concentrations assumed to be close to those *in vivo*. We infer that the defect lies primarily in the recruitment of catalytically important Mg^2+^. An isosteric C259-G~74~ base pair fully and a C258-G~75~ pair slightly restored catalytic performance *in vitro*, which supports the notion that G258/G259 form Watson--Crick base pairs with ptRNA 3′-[CC]{.ul}A, but also indicates that the base identity of G258 is important for enzyme function. This is remarkably similar to what has been found for *E. coli* RNase P ([@B8],[@B11],[@B12],[@B14]). Native PAGE experiments further unveiled some differences in RNA-folding equilibria between the wt and mutant P RNAs at low \[Mg^2+^\], but folding remained unaffected by the presence of the P protein. This raises the possibility that a folding defect of the C258/C259 mutant RNAs *in vivo* contributed to their phenotype. We finally addressed the question if RNase P can act on CCA-less ptRNAs in *B. subtilis* by 5′-RACE experiments in *B. subtilis* SSB320, an RNase Z-deficient strain that accumulates ptRNA transcripts with CCA-less 3′-extensions. We could demonstrate 5′-end maturation of such ptRNAs by RNase P *in vivo*, documenting that the presence of 3′-CCA is not an absolute requirement for catalysis by *B. subtilis* RNase P. We conclude that the *in vivo* defects of type B *rnpB* mutant alleles result from a global deterioration of tRNA 5′-end maturation; alternatively, a disruption of the CCA interaction may affect a subset of tRNAs more severely than the majority of tRNAs.

MATERIALS AND METHODS
=====================

Bacteria
--------

*Bacillus subtilis* strain SSB318 ([@B17]) was used for complementation studies and SSB320 ([@B20]) for 5′-RACE experiments.

Complementation studies in strain SSB318
----------------------------------------

Recombinant *rnpB*-coding pHY300 derivatives were introduced into SSB318 using the LS/HS-medium protocol as described ([@B17]). Residual IPTG was removed by centrifugation (1 min, 7000 g) and resuspension of the cells in LB medium. Cells were plated in parallel on LB agar plates with or without 1 mM IPTG and containing 0.5 µg/ml erythromycin, 12.5 µg/ml lincomycin and 30 µg/ml tetracycline (to select for the presence of pHY300). In cases of poor transformation efficiency, cells were first plated exclusively in the presence of IPTG. For plasmids encoding *rnpB* or *rnpA* genes under control of the P~xyl~ promoter, the medium was additionally supplemented with 2% (w/v) glucose or 2% (w/v) xylose. For the construction of complementation plasmids, see Supplementary Data.

Growth curve monitoring
-----------------------

*Bacillus subtilis* SSB318 cells were grown overnight at 37°C in the presence of the appropriate antibiotics and 1 mM IPTG. IPTG was then washed out by repeated centrifugation and resuspension of the cell pellet in LB without IPTG; the final cell pellet was resuspended in LB, adjusted to a starting OD~578~ of 0.05--0.1 in 50 ml LB supplemented with the respective antibiotics and grown at 37°C under shaking.

*In vitro* transcription and 5′-endlabeling
-------------------------------------------

T7 runoff transcription and 5′-endlabeling was performed as described ([@B11]). For transcription of ptRNA^Gly^ (and G74 and G75 variants thereof) as well as *E. coli* P RNAs, see ([@B14]). For transcription of *B. subtilis* wt and mutant P RNAs, as well as other mutant substrates ([Table 5](#T5){ref-type="table"}), see Supplementary Data.

Preparation of recombinant RNase P protein
------------------------------------------

*Bacillus subtilis* RNase P protein carrying an N-terminal His-tag (His-tagged peptide leader: MRGSHHHHHHGS, encoded in plasmid pQE-30 in *E. coli* JM109) was prepared as described for the *E. coli* RNase P protein ([@B14]).

Processing assays
-----------------

RNase P holoenzyme kinetics were performed in buffer F (2 or 10 mM MgCl~2~, 50 mM Mes pH 6.1, 100 mM KCl) or buffer KN (20 mM HEPES-KOH, pH 7.4, 2 or 4.5 mM Mg(OAc)~2~, 150 mM NH~4~OAc, 2 mM spermidine, 0.05 mM spermine and 4 mM β-mercaptoethanol) ([@B21]). *In vitro* reconstitution of RNase P holoenzymes was performed as follows: P RNAs were incubated in the respective buffer for 5 min at 55°C and 50 min at 37°C, after which RNase P protein was added, followed by another 5 min at 37°C before addition of substrate. Processing reactions were started by combining enzyme and substrate solutions (final volume 10 µl) and assayed at 37°C.

Folding analysis by native PAGE
-------------------------------

Folding analyses were conducted exactly as described ([@B14]).

5′-RACE
-------

SSB320 cells were grown in parallel either in the presence or absence of IPTG to an OD~578~ of 0.6. Total RNA was isolated using the TRIzol (Invitrogen) method (here we did not use the RNeasy Mini/Midi Kit from Qiagen employed below, because its cutoff of about 200 nt would have resulted in a substantial loss of smaller RNAs, such as the tRNA transcripts of interest in this experiment), followed by DNase I treatment (Turbo DNase, Ambion). In order to include primary transcripts, one half of total RNA was treated with tobacco acid pyrophosphatase (TAP, Epicentre). Afterwards, the adapter oligonucleotide A1 (5′-GTC AGC AAT CCC TAA G[GA G]{.ul}; the three 3′-terminal residues were RNA, the remainder DNA) was ligated to the 5′-monophosphates of RNA molecules. Specific primers were designed to map 3′-unprocessed transcripts of *trnSL-Ala1* (primer 180, 5′-TCG AAT AAG GGT TTA AAG GTA TGG AG) and *trnSL-Val2* (primer 178, 5′-CTG CGC AAG GGT TTA AGC TAT GAT T). These primers were used in cDNA synthesis and in combination with primer 5′-GTC AGC AAT CCC TAA GGA G (matches the sequence introduced by the adapter oligonucleotide) in the following PCR reaction. PCR products were identified by native 8% PAGE, gel-purified and cloned into pCR2.1-TOPO for sequencing. Five clones were sequenced for each tRNA. For the ptRNA^Gly^ control ([Figure 5](#F5){ref-type="fig"}, lanes 4--6), the reverse transcriptase primer was 5′-GAC TGG AGC GGG AGA CGG, yielding an RT-PCR product with an expected length of 112 bp.

Overexpression of *rnpA*---effect on P RNA levels
-------------------------------------------------

To determine *rnpB* expression levels in strain SSB318 complemented with *S. aureus* or *B. subtilis rnpB*wt or mutant alleles as a function of *B. subtilis rnpA* overexpression, cells were grown overnight at 37°C in 3 ml LB medium supplemented with 1 mM IPTG, 12.5 µg/ml lincomycin, 0.5 µg/ml erythromycin and 30 µg/ml tetracycline. IPTG was then washed out by repeated centrifugation/resuspension of the cell pellet in LB without IPTG; the final cell pellet was then resuspended in LB, and adjusted to a starting OD~578~ of 0.05--0.1 in 50 ml LB; antibiotics (see above) and 2% xylose (w/v) were added and cells were grown at 37°C under aeration to an OD~578~ of 0.5--0.6. Aliquots of the cell suspensions were then diluted and plated in parallel on four plates (+xylose and +IPTG;+xylose and −IPTG;+glucose and +IPTG; +glucose and −IPTG) supplemented with antibiotics (all concentrations as in liquid media) to verify the original growth phenotype (retarded growth with mutant *rnpB* alleles in the absence of P~xyl~ *rnp*A, [Table 2](#T2){ref-type="table"}). Total RNA from the cultures was prepared using the RNeasy Mini/Midi Kit from Qiagen according to the protocol provided by the manufacturer, followed by DNase I treatment (Turbo DNase, Ambion). RT-PCR was performed with the Access RT-PCR System (Promega). PCR was stopped after 12 cycles within the exponential phase of amplification. Primers specific for *S. aureus rnpB* were 5′- GGG TAA TCG CTA TAT TAT ATA GAG G combined with either 5′- ATT TGG ATT GCT CAC TCG AGG G (5′-endlabeled in [Figure 3](#F3){ref-type="fig"}) or 5′- CTA GTA GTG ATA TTT CTA TAA GCC ATG (5′-endlabeled in Figure S1); primers specific for *B. subtilis rnpB* were 5′-CTT AAC GTT CGG GTA ATC GC and 5′- AAG TGG TCT AAC GTT CTG TAA GCC (5′-endlabeled in Figure S2); primers specific for *B. subtilis* ribosomal protein S18 were 5′- GCA GAG GCG GTC GTG CGA AA and 5′-ACG TGC GCG TTT GAT CGC TGC A (5′-endlabeled in [Figures 3](#F3){ref-type="fig"}, S1 and S2); RT-PCR reactions contained the normal amounts of unlabeled primers, and, in addition, trace amounts of the respective 5′-endlabeled primer.

RESULTS
=======

Complementation studies in *B. subtilis*
----------------------------------------

The *B. subtilis rnpB* mutant strain SSB318 was employed to investigate the *in vivo* role of the tRNA 3′-CCA interaction with type B RNase P RNA. In strain SSB318, the chromosomal *rnpB* gene is under the control of an IPTG-inducible P~spac~ promoter ([@B17]). In the absence of IPTG, cell growth depends on the presence of a functional *rnpB* gene provided on a plasmid (pHY300 derivatives in our study). Complementation was assayed for *B. subtilis* wt P RNA (*rnpB*wt), and the C258 or C259 mutant alleles (*rnpB*C258, *rnpB*C259). *B. subtilis rnpB*wt rescued cell growth in the absence of IPTG, as expected, no matter if expressed from the native *B. subtilis rnpB* promoter ([@B17]) or the xylose-inducible P~xyl~ promoter ([Table 1](#T1){ref-type="table"}). Even basal expression of P~xyl~ under repressed conditions (medium supplemented with glucose instead of xylose) sufficed for cell growth. In contrast, with complementation plasmids encoding *B. subtilis rnpB*C258 or *rnpB*C259 under control of the native *B. subtilis rnpB* promoter we could not get a single transformant in strain SSB318. For the *rnpB*C259 allele, some transformants were obtained after substituting the native for the P~xyl~ promoter; for some clones, we could indeed confirm the mutant *rnpB*C259 genotype by sequencing, whereas others turned out to be revertants to *rnpB*wt. However, cells expressing *rnpB*C259 had a lethal phenotype in the absence of IPTG, which may explain our severe cloning problems. We could not isolate a single colony expressing C258 P RNA. Table 1.Homologous complementation of *B. subtilis* RNase P mutant strain SSB318 by *B. subtilis rnpB* wild type and mutant alleles*rnpB* variants in pHY300+ IPTG− IPTGAldose*B. subtilis* P*~Bs\ rnpB~ rnpB*wt+ + ++ + +None*B. subtilis* P*~Bs\ rnpB~ rnpB*C258[^a^](#TF1){ref-type="table-fn"}None*B. subtilis* P*~Bs\ rnpB~ rnpB*C259[^a^](#TF1){ref-type="table-fn"}None*B. subtilis* P~xyl~ *rnpB*wt+ + ++ + +[^b^](#TF2){ref-type="table-fn"}Xylose or glucose*B. subtilis* P~xyl~ *rnpB*C258[^a^](#TF1){ref-type="table-fn"}*B. subtilis* P~xyl~ *rnpB*C259+ + +−Xylose*B. subtilis* P~xyl~ *rnpB*wt + P~xyl~ *rnp*A+ + ++ + +Xylose*B. subtilis* P~xyl~ *rnpB*C258 + P~xyl~ *rnp*A+ + ++ + [^c^](#TF3){ref-type="table-fn"}Xylose*B. subtilis* P~xyl~ *rnpB*C259 + P~xyl~ *rnp*A+ + ++ + +[^d^](#TF4){ref-type="table-fn"}Xylose*B. subtilis* P~xyl~ *rnpB*wt + P~xyl~ *rnp*A-stop+ + ++ + +Xylose*B. subtilis* P~xyl~ *rnpB*C258 + P~xyl~ *rnp*A-stop+ + +[^e^](#TF5){ref-type="table-fn"}−Xylose*B. subtilis* P~xyl~ *rnpB*C259 + P~xyl~ *rnp*A-stop+ + +−XylosepHY300+ + +−XylosepHY300 + P~xyl~ *rnpA*+ + +−XylosepHY300 + P~xyl~ *rnpA*-stop+ + +−Xylose[^1][^2][^3][^4][^5][^6][^7]

Simultaneous overexpression of *B. subtilis* rnpA
-------------------------------------------------

We recently reported increased viability of *E. coli* cells expressing the *E. coli rnpB*C293 mutant gene when simultaneously overexpressing the homologous P protein ([@B14]). We thus transformed *B. subtilis* SSB318 cells with plasmids encoding the *B. subtilis rnpA* gene and either *rnpB*wt, *rnpB*C258 or *rnpB*C259, with both *rnpA* and *rnpB* alleles under control of the xylose promoter. In the presence of xylose, conditions which fully induced *rnpA* expression, cell viability in the absence of IPTG could indeed be substantially improved for cells expressing *rnpB*C258 or *rnpB*C259. For *rnpB*C259, basal expression of the P~xyl~ promoter (in the absence of xylose) supported retarded growth of SSB318 cells in the absence of IPTG. In contrast, for *rnpB*C258 full induction of the xylose promoter was required, with growth still somewhat retarded relative to *rnpB*wt and *rnpB*C259 ([Table 1](#T1){ref-type="table"}). In conclusion, P protein overexpression restored growth of bacteria expressing the *rnpB* mutant alleles, but fitness did not fully reach that of bacteria expressing the *rnpB*wt allele. To demonstrate that *rnpA*-related rescue effects were due to higher expression levels of the *B. subtilis* P protein and not to unspecific effects caused by the presence of additional copies of the *rnpA* gene, we also tested complementation with an *rnpA* gene with two stop codons in its 5′-portion (*rnpA*-stop), thus directing expression of a truncated inactive protein ([@B5]). As expected, *rnpA*-stop expression was unable to restore growth of SSB318 bacteria expressing *rnpB*C258 or *rnpB*C259 ([Table 1](#T1){ref-type="table"}). Our findings document a lethal phenotype associated with point mutations at G258 and G259 in L15 of *B. subtilis* P RNA. However, concomitant overexpression of the P protein (also verified by Western-blot analysis, data not shown) largely rescued cell viability. Furthermore, the phenotype was more severe for the C258 than C259 mutant RNA.

Complementation with *S. aureus* P RNA
--------------------------------------

The heterologous type B RNA from *S. aureus* was included in our complementation analysis to broaden the general significance of our findings on the CCA interaction of type B RNase P RNAs. Residues G238 and G239 in *S. aureus* P RNA correspond to G258 and G259 of *B. subtilis* P RNA ([Figure 1](#F1){ref-type="fig"}A and B). Whereas *S. aureus rnpB*wt was fully functional in *B. subtilis* SSB318, the mutant alleles *rnpB*C238/C239 resulted in a significant growth defect, though not being lethal ([Table 2](#T2){ref-type="table"}). This was also confirmed by monitoring growth curves in liquid culture ([Figure 2](#F2){ref-type="fig"}). Here, the phenotypes of *rnpB*C238 and *rnpB*C239 were very similar, thus deviating from the observation that the *B. subtilis rnpB*C258 allele was more deleterious than *rnpB*C259 (see above). The growth defect caused by the *S. aureus rnpB*C238/C239 mutant alleles could be completely rescued by overexpression of *B. subtilis rnpA* ([Table 2](#T2){ref-type="table"}). Figure 2.Growth curves of SSB318 cells complemented with pHY300 derivatives, carrying *S. aureus rnpB*wt (squares) or *rnpB*C238 (triangles with apex at the top) or *rnpB*C239 (triangles with apex at the bottom) mutant alleles in the presence (+) or absence (−) of IPTG. The better growth of SSB318 bacteria expressing *S. aureus rnpB*wt (squares) relative to SSB318 carrying the empty vector and grown in the presence of IPTG (open circles) can be explained by the finding that IPTG-induced expression of the chromosomal *rnpB* gene in the SSB318 mutant strain is weaker than *rnpB* expression from the native promoter in the original strain W168 used to construct SSB318 (([@B17]), [Figure 3](#F3){ref-type="fig"} therein). Improved growth was also observed when we expressed *B. subtilis rnpB*wt from pHY300 in strain SSB318 (data not shown), showing that this effect is not specific for *S. aureus rnpB*. We conclude that plasmid-borne expression of *S. aureus* or *B. subtilis rnpB*wt saturates the cellular RNase P levels in SSB318 bacteria and thereby restores wild-type-like growth. Table 2.Heterologous complementation of *B. subtilis* RNase P mutant strain SSB318 by *S. aureus* (type B) *rnpB* alleles*rnpB* variants in pHY300+ IPTG−IPTGAldose*S. aureus* P*~Bs\ rnpB~ rnpB*wt+ + ++ + +None*S. aureus* P*~Bs\ rnpB~ rnpB*C238+ + ++None*S. aureus* P*~Bs\ rnpB~ rnpB*C239+ + ++None*S. aureus* P*~Bs\ rnpB~ rnpB*wt + P~xyl~ *rnp*A+ + ++ + +Xylose*S. aureus* P*~Bs\ rnpB~ rnpB*C238 + P~xyl~ *rnp*A+ + ++ + +Xylose*S. aureus* P*~Bs\ rnpB~ rnpB*C239 + P~xyl~ *rnp*A+ + ++ + +Xylose[^8][^9]

Complementation with *E. coli* P RNA
------------------------------------

We have recently shown that *E. coli* P RNA (type A) can functionally replace *B. subtilis* P RNA (type B) *in vivo*, no matter if *E. coli rnpB*wt was expressed from its own native or from the *B. subtilis rnpB* promoter, and even a single copy of *E. coli rnpB*wt integrated into the *amyE* site of the *B. subtilis* chromosome was sufficient for cell viability ([@B17]). Since the *S. aureus rnpB*C238/C239 mutant alleles displayed a somewhat relaxed phenotype relative to *B. subtilis rnpB*C258/C259, we also tested function of the corresponding *E. coli* mutant alleles (*rnpB*C292/C293) in the *B. subtilis* background of strain SSB318. The *E. coli* mutant alleles were unable to restore growth under non-permissive conditions (without IPTG, Table S1). Even when co-expressed with *B. subtilis rnpB* (in the presence of IPTG), the *E. coli rnpB*C292/C293 mutant alleles impaired cell growth; overexpression of *B. subtilis rnpA* did not rescue this growth defect (Table S1).

Overexpression of *rnpA*---effect on P RNA levels
-------------------------------------------------

The complementation results shown in [Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"} revealed a rescue of the *B. subtilis rnpB*C258/C259 and *S. aureus rnpB*C238/C239 mutant phenotypes when the *B. subtilis* P protein was overexpressed. One explanation may be that higher levels of P protein increase the steady-state level of RNase P holoenzyme, thereby alleviating the processing defects caused by the mutant alleles. To test this possibility, we initially used SSB318 bacteria expressing the *S. aureus rnpB* mutant alleles, because here the rescue by *rnpA* overexpression was complete, reducing the risk that spontaneous mutant bacteria might have dominated the liquid cultures. PCR reactions were limited to 12 cycles, because under these conditions product yields were essentially linearly dependent on RNA template amounts ([Figure 3](#F3){ref-type="fig"}, lanes 25--30). The mRNA for ribosomal protein S18 served as the control to be able to assess experimental fluctuations. Overexpression of *rnpA* caused, on average, a 3- to 5-fold increase in the yields for the P RNA-specific product (based on five individual experiments), independent of whether bacteria expressed the *rnpB*wt or one of the mutant alleles ([Figure 3](#F3){ref-type="fig"}, lanes 1--12). No increase in the S18-specific RT-PCR product was observed upon overexpression of *rnpA* (lanes 13--24). Essentially the same results were obtained when the RT-PCR analysis was performed with a primer pair covering the 5′- and 3′-terminal regions of *S. aureus* P RNA in order to detect full-length P RNAs (Figure S1). This finding ruled out the possibility that partially degraded P RNA molecules might have contributed to the RT-PCR products in [Figure 3](#F3){ref-type="fig"}. We also analyzed the levels of full-length *B. subtilis* P RNA as a function of *rnpA* overexpression. For the *B. subtilis rnpB*C258/C259 alleles, we could not include the control experiment (without *rnpA* overexpression), as SSB318 bacteria expressing these alleles did not grow under non-permissive conditions (−IPTG; [Table 1](#T1){ref-type="table"}); also, growth was impaired for *rnpB*C258, despite *rnpA* overexpression ([Table 1](#T1){ref-type="table"}), and this defect was even more pronounced in liquid culture (data not shown). For the above reasons, we compared P RNA levels for *B. subtilis* wt P RNA in the absence of a plasmid-borne *rnpA* gene with those for wt and C259 P RNAs in the presence of overexpressed P protein. As for *S. aureus* P RNA, we detected increased *B. subtilis* P RNA levels due to *rnpA* overexpression (Figure S2); intensity of the RT-PCR product for the C259 mutant RNA was reproducibly found to be somewhat lower than the signal for the wt P RNA, suggesting that the C259 mutation (and, by inference, the C258 mutation) may result in somewhat decreased P RNA levels. Overall, our RT-PCR results demonstrate that overexpression of the P protein causes an increase in the steady-state levels of P RNA, and by inference of the RNase P holoenzyme, which explains the observed rescue effects ([Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). Figure 3.Radioactive reverse transcription PCR (RT-PCR) analysis of strain SSB318 complemented with *S. aureus rnpB*wt or *rnpB*C238/C239. PCR products were analyzed on a 10% polyacrylamide/8 M urea gel. Lanes 1--30: total RNA from SSB318 complemented with *S. aureus rnpB*wt (lanes 1--4 and 13-16), *rnpB*C238 (lanes 5--8, 17--20 and 25--30) or *rnpB*C239 (lanes 9--12 and 21--24) grown at 37°C in the absence of IPTG and in the presence of 2% xylose (w/v); amounts of total RNA were 200 ng in lanes 1--24, 26 and 29, 100 ng in lanes 25 and 28, and 400 ng in lanes 27 and 30. P~xyl~ *rnpA*: presence (+) or absence (−) of a xylose-inducible plasmid-encoded *B. subtilis rnpA* gene. Lanes 1--12 and 25--27: primers specific for *S. aureus rnpB (rnpB)*; lanes 13--24 and 28--30: primers specific for the mRNA encoding *B. subtilis* ribosomal protein S18 (S18). AMV: presence (+) or absence (−) of reverse transcriptase. For details on RT-PCR, see the Material and Methods section. Lanes 25--30 document that the amount of RT-PCR product was sensitive to RNA template concentration. The figure illustrates a representative experiment, but the results shown here were reproduced in five individual experiments using three independent total RNA preparations.

*In vitro* processing of ptRNA by *B. subtilis* RNase P holoenzymes
-------------------------------------------------------------------

To shed light on the nature of the *in vivo* defect of the C258/C259 mutant P RNAs, we analyzed the kinetics of *B. subtilis* RNase P holoenzymes assembled *in vitro*. The rescue effect observed when the *B. subtilis* P protein was overexpressed ([Table 1](#T1){ref-type="table"}) pointed, among several possibilities, to a protein affinity defect of the mutant P RNAs. We thus tested the activity of *B. subtilis* wt and mutant holoenzymes as a function of P protein concentration. We applied a buffer system which has been used for *B. subtilis* holoenzyme kinetics, containing 10 mM MgCl~2~, 50 mM Mes pH 6.1 and 100 mM KCl (referred to as buffer F10; adapted from ([@B22])). Surprisingly, activities were indistinguishable for the wt and mutant holoenzymes at all P protein concentrations (Figure S3). We then decreased the Mg^2+^ concentration to 2 mM (buffer F2), assuming that this more closely mimics the intracellular free Mg^2+^-concentration (1--2 mM) ([@B23]). Now the two mutant holoenzymes were more than 100-fold less active than wt RNase P ([Table 3](#T3){ref-type="table"}) when acting on ptRNA^Gly^ with a canonical 3′-CCA terminus (termed ptRNAwt in the following). However, combining the C259 enzyme with the mutant substrate ptRNAG74, restoring base pairing to the C259 P RNA, resulted in cleavage efficiencies essentially identical to those for the wt enzyme acting on ptRNAwt, whereas the wt and C258 enzymes cleaved ptRNAG74 at a more than 100-fold decreased rate. Likewise, the C258 mutant enzyme performed best with ptRNAG75 as the substrate, but the improvement in catalytic performance was only 2- to 6-fold ([Table 3](#T3){ref-type="table"}). This indicated that nt258 and 259 indeed form Watson--Crick base pairs with C75 and C74 of tRNA 3′-CCA. However, only the isosteric C259-G74 pair, but not the C258-G75 pair, in the E--S complex fully restored activity to that of wt complexes, illustrating the importance of G258 identity. A rescue of activity in the presence of the ptRNAG74 substrate was also observed for chimeric holoenzymes composed of the *B. subtilis* P protein and the *S. aureus* C239 mutant P RNA partially purified from SSB318 bacteria (data not shown). Table 3.Cleavage activity of *B. subtilis* wt and mutant RNase P holoenzymes acting on ptRNA^Gly^ wt and G74 or G75 mutant substrates at 2 mM Mg^2+^ and two protein concentrationsP RNAptRNA^Gly^*B. subtilis* P protein \[nM\]*k*~obs~*k*~rel~*B. subtilis* wtwt37.50.18 ± 0.031.0*B. subtilis* wtwt62.50.20 ± 0.041.1*B. subtilis* C258wt37.5(4.0 ± 2.0) × 10^−4^2.2 × 10^−3^*B. subtilis* C258wt62.5(1.3 ± 0.5) × 10^−3^7.2 × 10^−3^*B. subtilis* C259wt37.5(5.0 ± 1.0) × 10^−4^2.8 × 10^−3^*B. subtilis* C259wt62.5(1.6 ± 0.9) × 10^−3^8.9 × 10^−3^*B. subtilis* wtG7437.5(7.0 ± 1.0) × 10^−4^3.9 × 10^−3^*B. subtilis* wtG7462.5(1.3 ± 0.3) × 10^−3^7.2 × 10^−3^*B. subtilis* C258G7437.5(2.0 ± 1.0) × 10^−4^1.1 × 10^−3^*B. subtilis* C258G7462.5(3.0 ± 2.0) × 10^−4^1.7 × 10^−3^*B. subtilis* C259G7437.50.15 ± 0.0060.8*B. subtilis* C259G7462.50.30 ± 0.041.7*B. subtilis* wtG7537.5(3.0 ± 1.0) × 10^−4^7.2 × 10^−3^*B. subtilis* wtG7562.5(4.0 ± 3.0) × 10^−4^2.2 × 10^−3^*B. subtilis* C258G7537.5(6.0 ± 4.0) × 10^−4^3.3 × 10^−3^*B. subtilis* C258G7562.5(1.8 ± 0.2) × 10^−3^1.0 × 10^−2^*B. subtilis* C259G7537.5(1.4 ± 0.8) × 10^−4^0.6 × 10^−3^*B. subtilis* C259G7562.5(5.0 ± 0.1) × 10^−4^2.8 × 10^−3^[^10]

*In vitro* processing of ptRNA by *B. subtilis* holoenzymes in a buffer assumed to closely mimic intracellular conditions
-------------------------------------------------------------------------------------------------------------------------

We recently showed ([@B14]) for *E. coli* P RNA that folding of the catalytic RNA may be incomplete in low Mg^2+^ buffers, such as buffer F2 ([Table 3](#T3){ref-type="table"}). However, a buffer originally optimized for ribosome function (buffer KN, see Material and Methods) and containing spermine and spermidine appears to favor formation of a native fold ([@B14]). We therefore tested activity of the wt and mutant *B. subtilis* holoenzymes in buffer KN at two different Mg^2+^ concentrations (2 and 4.5 mM, KN2 and KN4.5). At 4.5 mM Mg^2+^, the mutant enzymes cleaved ptRNAwt at almost identical (C259) or 2-fold reduced (C258) rates. However, at 2 mM Mg^2+^, the rate dropped 2-fold for the wt enzyme, but about 6-fold for the mutant enzymes ([Table 4](#T4){ref-type="table"}). Thus, the minor shift from 4.5 to 2 mM Mg^2+^ exacerbated the defect of the mutant enzymes. To analyze if the defect was on the level of substrate affinity or holoenzyme stability, we tested processing activity under the same conditions but at a 5-fold higher holoenzyme concentration ([Table 4](#T4){ref-type="table"}). If substrate binding or holoenzyme stability were the major defect in reactions catalyzed by the C258/C259 mutant enzymes at 2 mM Mg^2+^, one would have expected that the ratio of cleavage rates for the mutant enzyme versus wt enzymes (*k*~rel~, [Table 4](#T4){ref-type="table"}) improves at the higher enzyme concentration. However, *k*~rel~ values rather showed a tendency to further decrease (0.12 and 0.13 versus 0.17 and 0.30, [Table 4](#T4){ref-type="table"}). Table 4.Cleavage rates for *B. subtilis* holoenzymes reconstituted *in vitro* at low Mg^2+^ concentrationsP RNAptRNA^Gly^Enzyme concentration\[Mg^2+^\]*k*~obs~*k*~rel~*B. subtilis* wtwt10 nM P RNA/ 37 nM RnpA4.59.7 ± 0.081.0*B. subtilis* C258wt10 nM P RNA/ 37 nM RnpA4.54.4 ± 0.080.45*B. subtilis* C259wt10 nM P RNA/ 37 nM RnpA4.58.4 ± 0.120.87*B. subtilis* wtwt10 nM P RNA/ 37 nM RnpA2.04.6 ± 0.091.0*B. subtilis* C258wt10 nM P RNA/ 37 nM RnpA2.00.8 ± 0.010.17*B. subtilis* C259wt10 nM P RNA/ 37 nM RnpA2.01.4 ± 0.030.30*B. subtilis* C259G7410 nM P RNA/ 37 nM RnpA2.06.5 ± 0.08*B. subtilis* wtwt50 nM P RNA/ 185 nM RnpA2.047.7 ± 0.681.0*B. subtilis* C258wt50 nM P RNA/ 185 nM RnpA2.05.9 ± 0.070.12*B. subtilis* C259wt50 nM P RNA/ 185 nM RnpA2.06.2 ± 0.050.13[^11]

We also analyzed cleavage of ptRNAG74 by the C259 mutant enzyme in buffer KN2 ([Table 4](#T4){ref-type="table"}). This fully restored the cleavage rate to that of the wt enzyme, in line with the results of [Table 3](#T3){ref-type="table"}.

Activity assays performed with chimeric holoenzymes consisting of *E. coli* P RNA (wt and the corresponding C292/C293 mutant variants) and the *B. subtilis* P protein (Table S2) resulted in essentially the same findings as with the *B. subtilis* holoenzymes.

Analysis of *B. subtilis* P RNA folding equilibria
--------------------------------------------------

Incomplete ([@B24]) or aberrant folding might have contributed to the *in vivo* and *in vitro* phenotypes of the C258/C259 mutant P RNAs. To address this possibility, we performed a native PAGE analysis using the same buffer systems as for the kinetic experiments. When 5′-endlabeled wt, C258 or C259 P RNAs were directly loaded (after gel purification and ethanol precipitation) onto the native gel without a preincubation step, under all four tested conditions two major bands appeared, which we termed I~1~ and I~2~ ([Figure 4](#F4){ref-type="fig"}, lanes 1--3). We are aware that I~1~ and I~2~ observed in the presence of 2 mM Mg^2+^ during electrophoresis may not necessarily be identical to those seen at 10 mM Mg^2+^. Upon P RNA preincubation for 55 min at 37°C (37°C) or for 5 min at 55°C followed by 50 min at 37°C (55/37°C), a faster migrating conformer appeared, which we assign to the native fold (termed 'N'), in line with a previous study ([@B19]). Remarkably, in buffer F2 (2 mM Mg^2+^) the N conformer was much less populated with the two mutant than with the wt P RNA ([Figure 4](#F4){ref-type="fig"}, lanes 4--12). This difference was largely reduced in buffer KN2. When preincubation was performed in buffers F10 and KN4.5 (10 and 4.5 mM Mg^2+^, respectively) and native PAGE at 10 mM Mg^2+^, differences between wt and mutant P RNAs were further mitigated (lanes 4--9) and essentially abolished after preincubation at 55/37°C (lanes 10--12). No substantial changes were seen when the P protein was added to the preincubation mix (lanes 4--6 versus 7--9). In summary, our native PAGE analysis indicates that (i) the KN2 buffer containing spermine and spermidine favors formation of the native fold relative to the F2 buffer and (ii) folding differences can be considered insignificant in buffer KN4.5 combined with our standard preincubation (5 min at 55°C, 50 min at 37°C). The data in [Figure 4](#F4){ref-type="fig"} illustrate that the folding equilibria of wt and C258/C259 mutant RNase P RNAs are sensitive to the buffer conditions. As we do not know the exact ionic milieu *in vivo*, a contribution from impaired folding of the mutant P RNAs to their growth defect *in vivo* cannot be excluded. Figure 4.Analysis of folding equilibria for wt and C258/C259 mutant *B. subtilis* P RNAs by native PAGE. RNAs (50 fmol, 5′-endlabeled) were preincubated either in buffer F containing 2 mM (F2) or 10 mM (F10) Mg^2+^, or in buffer KN containing 2 mM (KN2) or 4.5 mM (KN4.5) Mg^2+^ in a volume of 4--5 µl (for buffer F and KN compositions, see Materials and Methods). Lanes 1--3: no preincubation (kept at 4°C); lanes 4--6: preincubation of P RNAs for 70 min at 37°C; lanes 7--9: preincubation of P RNAs for 55 min at 37°C, addition of 1 µl *B. subtilis* P protein (final concentration 37 nM) and further incubation for 15 min at 37°C; lanes 10--12: as in lanes 7--9, but preincubation of P RNAs for 5 min at 55°C and 50 min at 37°C. Samples were run on 11.25% polyacrylamide gels in 1× THE buffer supplemented with 100 mM NH~4~OAc and either 2 mM (F2, KN2) or 10 mM (F10, KN4.5) MgCl~2~.

Processing of CCA-less ptRNAs
-----------------------------

Since in *B. subtilis* only two-thirds of the tRNA genes encode 3′-CCA, the question arose whether tRNA transcripts not encoding 3′-CCA have to undergo 3′-end processing and CCA addition before 5′-end maturation by RNase P can occur. To address this question, we constructed ptRNA^Gly^ 3′-variants, either encoding 3′-U~73~**CCA**AUA, 3′-U~73~**UAA**AUA or ending with the discriminator nucleotide (3′-U~73~ = ΔCCA); UAA instead of CCA downstream of the discriminator base is found in the native *B. subtilis trnI-Thr* precursor ([@B20]). Processing of these substrates by wt RNase P was tested in buffer KN, either at 4.5 or 2 mM Mg^2+^, and for 2 mM Mg^2+^ also at a 5-fold higher P RNA and P protein concentration ([Table 5](#T5){ref-type="table"}). The obtained pattern of relative cleavage rates roughly mirror-imaged what we had seen with the C258/C259 mutant enzymes in [Table 4](#T4){ref-type="table"}: (i) the cleavage rate was reduced for the UAA and ΔCCA variant, and the ratio of rates for the mutant versus canonical substrate worsened when the Mg^2+^ concentration was reduced from 4.5 to 2 mM; (ii) a 5-fold increase in P RNA and protein concentration did not improve performance of the mutant substrates relative to the canonical ptRNA ([Table 5](#T5){ref-type="table"}), suggesting that substrate affinity is not the major cause of the defect.

5′-RACE experiment of *trnSL-Ala1* and *trnSL-Val2*
---------------------------------------------------

*In vitro* processing of the CCA-less substrates was impaired but not abolished, raising the question whether this residual activity would suffice for RNase P cleavage of CCA-less tRNA transcripts *in vivo*. This was addressed by 5′-RACE experiments. For this purpose, we used strain SSB320, in which the chromosomal *rnz* gene (encoding RNase Z) is put under control of the IPTG-inducible P~spac~ promoter. In *B. subtilis*, RNase Z is involved in the 3′-maturation of tRNA primary transcripts lacking the CCA motif. We chose two native tRNAs (*trnSL-Ala1* and *trnSL-Val2*), which were shown to accumulate as 3′-precursors in strain SSB320 when *rnz* expression is decreased ([@B20]). Both tRNAs are transcribed from monocistronic genes with expected 5′-precursor segments of 8 nt (*trnSL-Ala1*) and 38 nt (*trnSL-Val2*), and both are 3′-extended by their transcription terminator stem-loop ([Figure 5](#F5){ref-type="fig"}A) ([@B20]). To ensure that only tRNAs with unprocessed 3′-ends were reverse transcribed during 5′-RACE, we designed a primer for reverse transcription whose 5′-proximal and central portion targeted the 3′-precursor sequences ([Figure 5](#F5){ref-type="fig"}A). A control experiment performed with RNA from SSB320 cells grown in the presence of IPTG (normal RNase Z expression) did not produce RT-PCR products ([Figure 5](#F5){ref-type="fig"}B, lane 3), demonstrating that our primer was specific for the 3′-extended tRNA. Using total RNA isolated from SSB320 cells grown in the absence of IPTG we obtained a prominent 5′-RACE product, roughly corresponding to the size of 5′-matured 3′-precursor tRNA (*ca*. 110 nt; [Figure 5](#F5){ref-type="fig"}B, lane 1). An additional treatment with tobacco acid pyrophosphatase (TAP; to permit RT-PCR of primary transcripts with 5′-triphosphates) did not give rise to an additional RT-PCR product ([Figure 5](#F5){ref-type="fig"}B, lane 2). We further controlled for TAP activity by adding a T7 primary transcript of ptRNA^Gly^ ([Figure 1](#F1){ref-type="fig"}D, carrying a 5′-triphosphate) to the total cellular RNA pool ([Figure 5](#F5){ref-type="fig"}B, lanes 5 and 6). In the case of inefficient 5′-end processing we would have expected a product extended by 8 nt for tRNA^Ala1^ ([@B20]). To ensure that RT-PCR products corresponded to 5′-matured transcripts, we cloned the main band of [Figure 5](#F5){ref-type="fig"}B (lanes 1 and 2, indicated by the arrow) into the pCR2.1-TOPO vector (Invitrogen) and sequenced 5 clones (the same was done for *trnSL-Val2*; data not shown). Sequencing analysis confirmed mature 5′-ends for both tRNAs. This was surprising as we would have anticipated, based on our kinetic *in vitro* results ([Table 5](#T5){ref-type="table"}), to detect at least some 3′-extended tRNA with immature 5′-ends. In any case, these results clearly demonstrated that RNase P processing can proceed *in vivo* in the absence of the CCA interaction. Figure 5.5′-RACE analysis of *B. subtilis trnSL-Ala1* 3′-precursors. (**A**) Secondary structure of tRNA^Ala1^ primary transcripts with RNase P and Z cleavage sites indicated; the arrow aligning the transcription terminator and tRNA acceptor stem indicates the position of the primer ('180') used for the 5′-RACE experiment; the boxed nucleotides (U74, A75) are replaced with the two C residues after RNase Z cleavage and CCA addition. (**B**) Analysis of 5′-RACE RT-PCR products on a native 8% PAA gel; M, 10-bp ladder as size marker; in lanes 1--3, primer '180' (see above) and in lanes 4--6  a primer (see the Materials and Methods section) specific for *T. thermophilus* tRNA^Gly^ ([Figure 1](#F1){ref-type="fig"}D) was used. The arrow on the left indicates the main amplification product obtained with primer '180'; its size was expected for a tRNA^Ala1^ processing intermediate with a mature 5′-end but carrying the entire 3′-extension as in the primary transcript; this type of product was only detected in total RNA isolated from SSB320 cells grown in the absence of IPTG (lanes 1 and 2), but not in the presence of IPTG (lane 3); before reverse transcription, total RNA preparations were treated (+TAP) or not treated (− TAP) with tobacco acid pyrophosphatase (TAP). In lanes 5 and 6, total RNA from SSB320 cells grown in the absence of IPTG was supplemented with *in vitro* transcribed ptRNA^Gly^ ([Figure 1](#F1){ref-type="fig"}D; 0.05 *A*~260~ units ptRNA^Gly^ added to 1.0 *A*~260~ unit of total cellular RNA) starting with 5′-pppG. A product corresponding to the size of ptRNA^Gly^ was only detected after TAP treatment (lane 6), but not without TAP treatment (lane 5) or without addition of *in vitro* transcribed tRNA^Gly^ (lane 4), thus confirming that TAP was active. Table 5.Cleavage rates for the *B. subtilis* wild-type RNase P holoenzyme acting on substrates with 3′-end variations at low magnesium concentrationsptRNA^Gly^Enzyme concentration\[Mg^2+^\]*k*~obs~*k*~rel~U7310 nM P RNA/ 37 nM RnpA4.54.3 ± 0.080.36U73UAAAUA10 nM P RNA/ 37 nM RnpA4.53.3 ± 0.050.28U73CCAAUA10 nM P RNA/ 37 nM RnpA4.511.8 ± 0.151.0U7310 nM P RNA/ 37 nM RnpA2.01.5 ± 0.010.21U73UAAAUA10 nM P RNA/ 37 nM RnpA2.01.4 ± 0.010.2U73CCAAUA10 nM P RNA/ 37 nM RnpA2.07.0 ± 0.041.0U7350 nM P RNA/ 185 nM RnpA2.09.5 ± 0.080.19U73UAAAUA50 nM P RNA/ 185 nM RnpA2.06.8 ± 0.030.13U73CCAAUA50 nM P RNA/ 185 nM RnpA2.049.9 ± 0.431.0[^12]

DISCUSSION
==========

*In vivo* phenotypes of P RNAs with disrupted CCA interaction
-------------------------------------------------------------

We have investigated the tRNA 3′-CCA interaction with type B RNase P under *in vivo* conditions, using *B. subtilis* mutant strain SSB318 which has the chromosomal *rnpB* gene under control of the IPTG-inducible P~spac~ promoter ([@B17]). For this purpose, complementation efficiencies of *B. subtilis rnpB*wt relative to *rnpB*C258/C259 mutant alleles were analyzed in strain SSB318 under non-permissive conditions (−IPTG). The latter two *rnpB* alleles encode P RNAs with point mutations of the nucleotides thought to be involved in the CCA interaction. We also tested the functionality of *S. aureus rnpB*wt and its mutant *rnpB*C238/C239 alleles (as representatives of a heterologous type B P RNA) and that of the corresponding *E. coli rnpB*C292/C293 alleles representing type A RNase P RNA architecture. All *rnpB*wt alleles (*B. subtilis, S. aureus, E. coli*) were functional in SSB318 bacteria ([Tables 1](#T2){ref-type="table"}, [2](#T2){ref-type="table"} and S1). However, the mutant P RNA alleles resulted either in a severe growth defect (*S. aureus rnpB*C238/C239; [Table 2](#T2){ref-type="table"}) or were even lethal (*B. subtilis rnpB*C258/C259 and *E. coli rnpB*C292/C293; [Tables 1](#T1){ref-type="table"} and S1). Overexpression of the *B. subtilis* P protein partially (for *B. subtilis rnpB* alleles) or fully (for *S. aureus rnpB* alleles) restored cell viability of SSB318 bacteria expressing the mutant *rnpB* alleles ([Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). The rescue effect was also observed for the *E. coli* C293 mutant RNA in its natural host ([@B14]), but was not scrutinized there. Here we could attribute the rescue to increases in P RNA steady-state levels owing to P protein overexpression ([Figures 3](#F3){ref-type="fig"}, S1 and S2). These findings demonstrate, for the first time, that the CCA interaction is important for the vitality of bacteria encoding a type B RNase P RNA (*B. subtilis* in this study), but not necessarily essential, as inferred from the complementation results with the mutant *rnpB* alleles from *S. aureus* ([Table 2](#T2){ref-type="table"}). RNase P is able to cleave CCA-less ptRNAs *in vivo*, as inferred from 5′-RACE in the RNase Z mutant strain ([Figure 5](#F5){ref-type="fig"}). Since RNase Z, which acts on CCA-less tRNA 3′-precursors, has largely impaired activity on ptRNAs with long 5′-leaders, RNase P cleavage was proposed to precede RNase Z cleavage on CCA-less ptRNAs carrying expanded 5′- in addition to 3′-extensions ([@B20]). Our results verify this hypothesis. The finding that *B. subtilis* RNase P is able to process CCA-less ptRNAs then raises the question why the C258/C259 (or C238/C239) mutations caused a lethal (or severe) phenotype in the presence of normal amounts of P protein ([Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). Most likely, the general deceleration in ptRNA maturation kinetics adds up to a collective defect caused by the incapability of the tRNA biosynthesis machinery to meet the demands of the protein synthesis apparatus. This defect is mitigated when the steady-state amounts of the RNase P holoenzyme increase severalfold as a result of P protein overproduction. It also cannot be ruled out that disruption of the CCA interaction may impair 5′-maturation of a subset of ptRNAs more severely than that of the bulk of ptRNAs.

P protein overexpression leads to increases in P RNA steady-state levels ([Figures 3](#F3){ref-type="fig"}, S1 and S2), and, by inference, to increases in cellular RNase P holoenzyme concentrations. This is remarkable, taking into account that the P protein only covers a small surface area of the RNA subunit ([@B2]). In a study on P RNA metabolism in *E. coli* ([@B25]), it was found that *rnpB* primary transcripts can undergo either 3′-end maturation or oligoadenylation resulting in degradation. A knockout of poly(A) polymerase (*pcnB*) blocked the degradation pathway and consequently increased the level of 3′-precursor P RNA. Since these higher levels of 3′-precursor P RNA did not entail an increase in the level of mature P RNA, the authors proposed that mature RNase P RNA may only stably accumulate when complexed with its protein subunit ([@B25]). Our results ([Figures 3](#F3){ref-type="fig"}, S1 and S2) are consistent with this model, suggesting similar mechanisms to regulate cellular RNase P levels in *E. coli* and *B. subtilis* despite fundamentally different P RNA maturation pathways in the two organisms. Whereas the mature 5′- and 3′-ends of *B. subtilis* P RNA appear to be generated by autolytic processing of precursor P RNA ([@B26]), *E. coli* P RNA primary transcripts are mainly intitiated at the mature 5′-end, and 3′-precursor sequences are removed by RNase E followed by exonucleolytic removal of 1 or 2 remaining nucleotides ([@B25],[@B27]).

*In vitro* results
------------------

The importance of the CCA interaction in reactions catalyzed by type B RNase P holoenzymes has been underestimated in previous *in vitro* analyses ([@B15]). We could reconcile these earlier findings when we tested activity upon disruption of the CCA interaction at 10 mM Mg^2+^ (Figure S3), which has been the 'gold standard' magnesium concentration for the testing of bacterial holoenzymes. However, the CCA interaction becomes critical *in vitro* at low Mg^2+^ concentrations, such as 2 mM ([Tables 3 to 5](#T3 T4 T5){ref-type="table"}), assumed to better mimic the cellular milieu than 10 mM Mg^2+^.

Our kinetic data clearly demonstrate that tRNA 3′-CCA ends form Watson--Crick base pairs with two guanosines in the L15 loop of type B RNase P RNAs. Evidence for the base pairing with C~74~ was first suggested by a mutational study analyzing cleavage fidelity in the reaction catalyzed by the type B RNA from *M. hyopneumoniae* ([@B12]). As found for *E. coli* ([@B11],[@B14]), an isosteric C259-G~74~ base pair, but not a C258-G~75~ pair, fully restored catalytic performance of type B RNase P to that of the wt holoenzyme acting on ptRNA with a canonical 3′-CCA end ([Tables 3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}). This indicates that the base identity of the 5′-proximal G residue (G258 in *B. subtilis*) is critical for catalytic performance, as observed for G292 of *E. coli* P RNA ([@B11],[@B14]). For *E. coli*, the importance of G292 identity can be attributed to the finding that the N7 of G292 is sensitive to a c7-deaza modification, which was interpreted to indicate hydrogen bonding with the 6-amino group of A258 in the 5′-portion of L15 ([@B28]). By inference, G258 might interact in an analogous manner with one of the adenines (A251--A253, [Figure 1](#F1){ref-type="fig"}D) in L15 of *B. subtilis* P RNA.

Toward a better understanding of the defect of holoenzymes with a disrupted CCA interaction at low Mg^2+^, it is instructive to briefly discuss what is known about the metal ion binding properties of the L15 loop. In *E. coli*, the P15/L15/P16 region has been identified as a central Me^2+^ binding module in the active site of P RNA ([@B13],[@B29]). There are sites of prominent Pb^2+^ hydrolysis at two locations in the internal L15 loop (sites III and V). Binding of tRNA 3′-CCA suppresses, *in vitro* and *in vivo*, Pb^2+^ hydrolysis at sites III and V and creates a new prominent Pb^2+^ hydrolysis site (IVb) nearby ([@B30],[@B31]). This indicates a structural rearrangement of the P15/L15/P16 region and a concomitant re-coordination of metal ions upon formation of the G292-C~75~ and G293-C~74~ intermolecular base pairs. For *B. subtilis* P RNA, four out of nine prominent Pb^2+^ hydrolysis sites could also be assigned to its apical L15 loop ([@B32]). Combined with the phenotypic similarities of C258/C259 (C292/C293 in *E. coli*) mutations in the *E. coli* and *B. subtilis* systems, this supports the notion that the L15 loop is a central Me^2+^ binding module in the active site of type B RNAs as well.

Based on the results shown in [Figure 4](#F4){ref-type="fig"}, the low activity of mutant holoenzymes at 2 mM Mg^2+^ might have been caused by a P RNA folding defect. However, the results of [Table 5](#T5){ref-type="table"} argue against this view. When we deleted or mutated 3′-CCA in the substrate and assayed processing by wt RNase P, results were essentially a mirror image of what we had seen with the mutant enzymes acting on ptRNAwt (cf. [Tables 4](#T4){ref-type="table"} and [5](#T5){ref-type="table"}): catalytic performance for the mutant substrates relative to ptRNAwt deteriorated upon a reduction of \[Mg^2+^\] from 4.5 to 2 mM, and the relative catalytic performance for the mutant substrates did not improve at 5-fold higher P RNA and protein concentrations.

The slight reduction in the fraction of correctly folded C258/C259 mutant P RNA molecules relative to the wt P RNA upon a decrease in Mg^2+^ concentration from 4.5 to 2 mM ([Figure 4](#F4){ref-type="fig"}) is nonetheless remarkable. Though unlikely to be the major cause of the catalytic defect of the mutant P RNAs at 2 mM Mg^2+^, this finding is surprising as the L15 loop is thought to be quite unstructured in free P RNA based on its low resolution in the X-ray structure of *B. stearothermophilus* P RNA ([@B33]). Although the effect of the two point mutations in L15 on P RNA folding is not understood, this underscores the high sensitivity of P RNA folding to minimal structural changes at low Mg^2+^ concentrations.

Formally, the defect of the mutant P RNAs may also include contributions from impaired P protein and/or substrate affinity. However, at 10 mM Mg^2+^ (buffer F10) and increasing P protein concentrations, the reconstituted *B. subtilis* C258 and C259 mutant holoenzymes had activities indistinguishable from the wt enzyme (Figure S3). Likewise, in buffer KN supplemented with 4.5 mM Mg^2+^, activity reductions for the mutant holoenzymes were marginal. Only at 2 mM Mg^2+^, a substantial loss of activity was seen for the mutant enzymes, which correlated with the severe *in vivo* defects. Considering that a reduction of the Mg^2+^ concentration from 10 to 2 mM and particularly from 4.5 to 2.0 mM Mg^2+^ means only a minor decrease in ionic strength, we think it unlikely that the major defect of the mutant P RNAs is related to impaired P protein and/or substrate affinity. We rather infer that the L15 loop mutations lower the affinity for catalytically relevant Mg^2+^ ions that either directly contribute to the catalytic process or help to fold the L15--CCA interaction module as part of the active site in E--S complexes.

Differences between individual RNase P enzymes
----------------------------------------------

Despite the striking similarities in the CCA interaction of type A and B RNase P RNAs, some details are different. For *E. coli* RNase P, a 5-fold increase in P RNA and protein concentrations did not increase the cleavage rate for the C293 and C292 mutant enzymes at 2 mM Mg^2+^ ([@B14]). In contrast, the *B. subtilis* C258 and C259 mutant enzymes cleaved ptRNAwt at a 4-to 7-fold higher rate when P RNA and protein concentrations were increased 5-fold ([Table 4](#T4){ref-type="table"}). Activity of the chimeric holoenzymes consisting of *E. coli* P RNA and *B. subtilis* P protein also improved 2- to 3-fold at the higher RNase P subunit levels (Table S2). This finding, if not due to differences in the quality of the recombinant *E. coli* and *B. subtilis* P proteins, may point to a specific effect exerted by the *B. subtilis* P protein, possibly related to the observation that binding of P protein and substrate to P RNA are cooperative in the *B. subtilis* system ([@B34]).

Also, the *in vivo* phenotypes of the C258 (*B. subtilis*) and C238 (*S. aureus*) type B mutant P RNAs could be partially (*B. subtilis*; [Table 1](#T1){ref-type="table"}) or fully (*S. aureus*; [Table 2](#T2){ref-type="table"}) rescued by overexpression of *B. subtilis rnpA*. However, in the *E. coli* system essentially no rescue was observed for the corresponding *E. coli* C292 mutant P RNA upon overexpression of *E. coli rnpA* ([@B14]), suggesting that the guanine identity at this position is more critical in type A versus B enzymes. In this context, the better complementation efficiency of mutant *S. aureus* versus *B. subtilis rnpB* alleles was surprising. The *S. aureus rnpB*C238/C239 alleles even enabled some cell growth at normal P protein levels ([Table 2](#T2){ref-type="table"}). This might be related to the general problem associated with studies of homologous genes especially in *B. subtilis* which is known to possess an efficient recombination machinery. The presence of homologous *rnpB* genes carrying point mutations may activate genetic repair systems, especially if the mutant genes cause stress to the cells. This would explain our severe problems to clone the homologous *B. subtilis rnpB*C258/C259 alleles in SSB318 combined with the high number of wild-type revertants. Finally, the severeness of phenotypes for *B. subtilis rnpB*C258 and *E. coli rnpB*C292 exceeded that of *B. subtilis rnpB*C259 and *E. coli rnpB*C293, respectively ([Table 1](#T1){ref-type="table"}) ([@B14]). In contrast, the *in vivo* phenotypes of *S. aureus rnpB*C238 and *rnpB*C239 were indistinguishable ([Table 2](#T2){ref-type="table"}; [Figure 2](#F2){ref-type="fig"}), which we do not understand at present.

Despite some context dependence of L15 mutations, we can conclude from our findings that the Watson--Crick base-pairing interaction with tRNA 3′-[CC]{.ul}A is a common feature of the majority of bacterial type A and type B RNase P enzymes. This interaction is important but not necessarily essential for cellular function.
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[^1]: Growth of mutant strain SSB318 transformed with wild-type *B. subtilis rnpB* (*rnpB*wt) and mutant (*rnpB*C258, *rnpB*C259) alleles on plasmid pHY300; promoter types: P*~Bs\ rnpB~*, native *B. subtilis rnpB* promoter; P~xyl~, inducible xylose promoter; *B. subtilis rnpA* was overexpressed in parallel from the same plasmid; *rnpA*-stop designates the *B. subtilis rnpA* gene with two stop codons in the 5′-coding region. Cell growth was analyzed on LB plates (with appropriate antibiotics) in the presence (1 mM) or absence of IPTG; an aldose (xylose or glucose) at 2% (w/v) was added where indicated.

[^2]: \+ + +: growth with equal numbers of colonies on the corresponding + and − IPTG plates; ++: somewhat retarded growth, but equal numbers of colonies on + and − IPTG plates.; −: no growth;

[^3]: ^a^Unable to clone.

[^4]: ^b^Basal expression of xylose promoter (in the presence of 2% glucose) is sufficient for cell growth in the absence of IPTG.

[^5]: ^c^Basal expression of xylose promoter (in the presence of 2% glucose) is not sufficient for cell growth in the absence of IPTG.

[^6]: ^d^Basal expression of xylose promoter (in the presence of 2% glucose) is sufficient for cell growth in the absence of IPTG, but retarded cell growth.

[^7]: ^e^Here we succeeded to isolate a single colony with a stable *rnpB*C258 genotype; however, the majority of SSB318 cells transformed with *rnpB*C258 were still unstable and tended to form revertants to the wild type, most likely by recombination with the chromosomal *rnpB*wt gene.

[^8]: Growth of mutant strain SSB318 transformed with wild-type *S. aureus* (*rnpB*wt) and respective mutant alleles on plasmid pHY300; promoter types: P*~Bs\ rnpB~*, native *B. subtilis rnpB* promoter; P~xyl~, inducible xylose promoter; *B. subtilis rnpA* was overexpressed in parallel from the same plasmid. Cell growth was analyzed on LB plates in the presence (1 mM) or absence of IPTG; the aldose xylose was added to 2% (w/v) for pHY300 derivatives encoding *B. subtilis rnpA*.

[^9]: \+ + +: growth with equal numbers of colonies on the corresponding + and − IPTG plates; +: retarded cell growth, but equal numbers of colonies on + and − IPTG plates

[^10]: Assay conditions: 50 mM Mes pH 6.1, 100 mM KCl, 2 mM MgCl~2~; P RNA concentration was 20 nM, protein concentration as indicated and substrate concentration was 200 nM; 5′-endlabeled substrate was added in trace amounts (\<1 nM). *k*~obs~ is given in pmol substrate converted per pmol of P RNA per min; for *k*~rel~, individual *k*~obs~ values were divided by *k*~obs~ for the wt P RNA at 37.5 nM P protein and acting on ptRNAwt (first line); values are based on at least three independent experiments.

[^11]: Assay conditions: 20 mM Hepes pH 7.4 (37°C), 2 mM Mg(OAc)~2~, 150 mM NH~4~OAc, 2 mM spermidine, 0.05 mM spermine, 4 mM β-mercaptoethanol, and P RNA and *B. subtilis* P protein (RnpA) concentrations as indicated; the substrate concentration was 100 nM; 5′-endlabeled substrate was added in trace amounts (\<1 nM); *k*~obs~ is given in pmol substrate converted per pmol of P RNA per min; *k*~rel~ is defined as the ratio of *k*~obs~ obtained with the mutant versus wt holoenzyme under the respective conditions; values are based on at least four independent experiments.

[^12]: For assay conditions, see legend to [Table 4](#T4){ref-type="table"}; *k*~rel~ is defined as the ratio of *k*~obs~ obtained with the mutant versus canonical (U73CCAAUA) substrate under the respective conditions; values are based on at least four independent experiments.
